Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease
... primary endpoint of the change in the amount of kidney
interstitial capillary GL-3, the substrate that ... endpoint will be the change in the amount of kidney
interstitial capillary GL-3 as measured in kidney
biopsies using histology. Secondary endpoints ...
Afinitor(R) Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma, Leading to Phase III Trial
... (5 mg and 10 mg tablets) to treat advanced kidney
cancer after failure of treatment with sunitinib ... agencies globally for the treatment of advanced kidney
cancer. Afinitor is being studied in multiple ... the prevention of organ rejection in heart and kidney
transplant recipients. Certican was first ...
WORLD'S First Robotic Assisted Kidney Transplant Performed at Saint Barnabas Medical Center
... surgeon, Stuart R. Geffner, M.D., Director of kidney
and Pancreas Transplant Surgery, Saint Barnabas ... Surgical System to successfully implant a kidney
into a living recipient. This procedure revolutionizes kidney
transplant surgery, taking an open procedure to ...
IMPACT Study Showed Longer Valcyte(R) (valganciclovir hydrochloride tablets) Treatment Demonstrated Better Protection Against Cytomegalovirus (CMV) Disease One Year Post-Transplant
... the incidence of CMV disease by 56% in high-risk kidney
transplant patients within the first year ... Dr. Robert Gaston, Medical Director for kidney
and Pancreas Transplantation and Professor of ... study for the prevention of CMV disease in kidney
allograft recipients was a global, multi-center ...
Agennix Receives Fast Track Designation From FDA for Talactoferrin in Combination With Sunitinib for Renal Cell Carcinoma
RCC is the most common type of kidney
cancer, accounting for approximately 90 percent of kidney
tumors. According to the American Cancer Society, there are approximately 49,000 new cases of kidney
cancer diagnosed each year in the United States. ...
Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results
... Olmesartan Medoxomil Prevents Onset of Early kidney
Disease in Type 2 Diabetes Patients
SAN ... (T2DM). Microalbuminuria is an early sign of kidney
disease, as well as an important risk factor of ...
Diabetes is among the leading causes of kidney
failure.(4) High blood sugar levels and high ...
AUA Guideline: Full Kidney Removal Not Necessary for All Kidney Tumors
... kidney) is not the best treatment for most small kidney
tumors because it puts patients at risk for chronic kidney
disease and cardiovascular disease. ... are viable options for patients with early-stage kidney
tumors, according to a new clinical guideline ...
Phase 3 Trial of Nexavar in Chemotherapy-Naive Patients with Advanced Melanoma Does Not Meet Primary Endpoint
... for the treatment of patients with advanced kidney
cancer. Nexavar is also being evaluated by the ... breast cancer and as an adjuvant therapy for kidney
and liver cancer.
Important Safety ... hepatocellular carcinoma and advanced kidney
cancer, hypertension may occur early in the ...
Osprey Pharmaceuticals U.S.A., Inc. Initiates Phase Ib Clinical Trial in IgA Nephropathy
... to Evaluate Safety of CCL2-LPM for Inflammatory kidney
SAN FRANCISCO, April 14 /PRNewswire/ ... the treatment of IgA nephropathy, an inflammatory kidney
disease. Osprey Pharmaceuticals U.S.A. is ... axis plays a significant role in inflammatory kidney
diseases such as IgA nephropathy and diabetic ...
Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib
... tumor growth or death in patients with advanced kidney
cancer (4.9 vs. 1.9 months) and reduced the risk ... help us continue to offer patients with advanced kidney
cancer new ways to battle their ... an unmet medical need for patients with advanced kidney
cancer. Novartis has filed regulatory submissions ...
New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management
... alone and TRILIPIX alone. No unexpected liver, kidney
or muscle safety issues were identified in this ... by people with liver, gallbladder, or severe kidney
disease, nursing mothers, or those allergic to ... away. Rarely, muscle-related problems can cause kidney
damage and can be fatal. The risk of these side ...
DaVita Abstracts Accepted Into National Kidney Foundation's 2009 Spring Symposium
... Thirteen Abstracts Will Be Featured at Annual kidney
EL SEGUNDO, Calif., March 25 /PRNewswire/ -- DaVita Inc., a leading provider of kidney
care services for those diagnosed with chronic kidney
failure and disease (CKD), in conjunction with ...
DaVita Abstracts Highlight Latest Research Developments at Annual Dialysis Conference
... Abstracts Reveal Ground-breaking Information on kidney
Education and Modality Treatments
EL ... -- DaVita Inc., a leading provider of kidney
care services for those diagnosed with chronic kidney
disease (CKD), in conjunction with DaVita ...
Quark Pharmaceuticals Presents at Asia TIDES Conference
... clinical studies for the prevention of acute kidney
injury (AKI) and a Phase I/II clinical study for ... developed by Quark for the prevention of acute kidney
injury (AKI) following major cardiac surgery and of delayed graft function in kidney
transplantation. For the structure of these ...
Freezing Kidney Cancer: Hot Treatment Should Be New Gold Standard for Destroying Small Tumors
... March 9 /PRNewswire-USNewswire/ -- Freezing kidney
tumors -- using a safe minimally invasive ... such an early stage is truly significant news for kidney
cancer patients," he added.
It's important ... options -- especially since the incidence of kidney
cancer has been steadily increasing in this ...
For Old or Young Dialysis Patients, AV Fistulas Remain Pure Gold
... shows that for those individuals with chronic kidney
disease, it doesn't matter if you're young or ... Lebanon, N.H. When kidneys fail -- called chronic kidney
or end-stage renal disease -- treatment in the ... fistulas remain the gold standard of access for kidney
dialysis patients. They last longer, need less ...
Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function
transplantation to be Quark's second indication ... (DGF) in patients undergoing deceased donor kidney
transplantation. DGF represents Quark's second ... enrolling Phase I clinical trials in acute kidney
The multi-center, two-part ...
Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline in Renal Function and Arterial Stiffness in Older Adults
... adults is independently associated with chronic kidney
disease, and may be an independent predictor of ... adjusting for those that already had chronic kidney
disease at the outset of the study.
... and damaging to organs such as the heart, kidney
and skin among others. Collagen (a protein ...
Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH
... Perhaps most
noteworthy was the improvement in kidney
function observed with eculizumab
treatment. ... evaluate the effect of
Soliris on Chronic kidney
Disease (CKD), measured as an improvement or
... (3) Levey AS, Coresh J, Balk E, et al. National kidney
Practice Guidelines for ...
First Clinical Experience With Soliris(R) in Treating Patients With Two Rare Complement-Mediated Diseases Presented at ASH Annual Meeting
... as reduced number of circulating
platelets, and kidney
damage. In two patients with aHUS, ... of blood vessels, often causing acute kidney
progressing to end-stage kidney
disease. Those who survive aHUS often live
Latest RAD001 Study Results Show Further Increase in Time Without Tumor Growth in Patients With Advanced Kidney Cancer
... once-daily oral mTOR therapy for advanced kidney
EAST HANOVER, N.J., Sept. 16 ... of RAD001 (everolimus) for
patients with advanced kidney
cancer who have failed standard therapies.
... extended period of time in patients with advanced kidney
that progressed despite treatment with ...
RAD001 Granted Priority Review in the US Based on Potential to Fill Unmet Medical Need in Patients With Advanced Kidney Cancer
... therapy targeting mTOR to treat advanced kidney
cancer EAST HANOVER, N.J., Sept. 9 /PRNewswire/ ... significant benefit in
patients with advanced kidney
cancer after failure of standard treatment.
... of standard
treatment in patients with advanced kidney
cancer, RAD001 more than doubled
time without ...
Cylex Announces Plan for Multi-Center Trial of ImmuKnow(R) Assay in South Korea
... collaborate on studies of immunosuppression in kidney
transplant patients and role of cell-mediated ... the ages of 15 and 60 who undergo an
transplant and who are randomly assigned to ... monitor the immune status of
patients following kidney
transplantation. "The working hypothesis of ...
New Data Support Role for Monitoring of Cell-Mediated Immunity in Adult Patients Following Renal Transplantation
... in independent study of adult kidney
COLUMBIA, Md., Aug. 21 ... for organ rejection or infection
subsequent to kidney
Pablo Sanchez-Velasco and his ... in 81 immunosuppressed adults who
transplantation. The objective of their study was ...
DaVita Strives to Improve Quality of Life and Reduce Overall Costs of Kidney Care Through Community-Based Education
... -- DaVita Inc., a leading
provider of kidney
care services for those diagnosed with chronic ... out to more than 100,000 Americans through its kidney
You(R) program, which offers health ... seminars and useful tools to
help prevent kidney
disease brought on by risk factors like diabetes ...
Isis Highlights Robust Drug Portfolio for Diabetes and Obesity at ADA Conference
controlling glucose re-absorption in the kidney
and the target of ISIS
388626. In addition, Isis ... formation. -- Lowered SGLT2 mRNA levels in the kidney
by approximately 80% in all species tested, ... models, lowering levels of SGLT2 in the kidney
antisense drug demonstrated very potent ...
The Largest Ever Study of Diabetes Shows Intensive Glucose Control Reduces Serious Complications
... intensive treatment reduces
the risk of kidney
disease by one-fifth. Presented today at the ... serious
complications, particularly the risk of kidney
disease, one of the most
serious and disabling ... (by 10%), with a one-fifth reduction in kidney
disease (21%) and 30% reduction in the ...
University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients
... with Cylex
ImmuKnow(R) in the management of post kidney
transplant recipients," will
be presented on June ... clinical findings in patients undergoing kidney
Carreno is the Assistant ... Transplant Laboratories.
Patients undergoing kidney
transplantation were ...
Cryoablation Is Focus of 17 Clinical Studies at American Urological Association Annual Meeting
... invasive treatment for prostate cancer and kidney
Highlights from the 17 studies ... survival rates (more than five years) of kidney
cancer patients showed that laparoscopic kidney
cryoablation is an effective treatment in ...
RAD001 More Than Doubles Time Without Tumor Growth After Failure of Standard Treatment in Patients With Advanced Kidney Cancer
... new treatment option for patients
with advanced kidney
cancer who have failed standard therapies.
The ... show clinical benefit in patients with
cancer who have experienced treatment failure ... cell carcinoma (RCC)
In the United States, kidney
cancer accounts for approximately 3% of
all adult ...
Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients
action may have a positive effect on diabetic kidney
Patients with diabetes are at an ... high blood pressure and diabetic kidney
disease. Up to 73 percent
of patients with ... of diabetic patients will
progress to diabetic kidney
disease,(6) a devastating disease that ...
Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
treatment option for patients with advanced kidney
cancer who have failed
standard therapies will be ... the prevention
of organ rejection in heart and kidney
transplant recipients. Certican was
first ... other bisphosphonates have been known to
damage. Prior to each infusion, your doctor will ...
Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings
... (DARB), evaluate medical costs
related to chronic kidney
disease (CKD) patients with hypertension ... Stimulating Agents in Patients with Chronic kidney
Disease Patrick Lefebvre, M.A., Groupe ... Cost Considerations of Predialysis Chronic kidney
Disease Patients Receiving Erythropoietic ...
St. Jude Study Offers New Hope for Children With Kidney Tumors Deemed Inoperable
... Surgeons were able to save part of each kidney
in patients with
bilateral Wilms tumor, ... preoperative imaging
studies suggesting that kidney
preservation might not be possible.
"Many ... in an attempt to eradicate the cancer. If
is removed and the cancer recurs in the other ...
BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept(TM)
... reductions in chemotherapy-induced kidney
damage and vomiting
SAN ANTONIO and TOKYO, ... reduction in cisplatin-induced kidney
damage (nephropathy) and
a statistically ... to the study's size. Other side effects such as kidney
chemotherapy-induced vomiting were ...
Dynamis Therapeutics, Inc. Discovers RAGE Inhibitor
... to Develop Disease Treatments for Diabetic kidney
Disease and Retinopathy, Each ... to the arsenal of drugs to treat diabetic kidney
retinopathy, microvascular disease, ... Therapeutics to develop a
treatment for diabetic kidney
disease and blindness. Diabetes and ...
Northwestern Memorial Transplant Program Initiates New Study
... Study seeks to wean certain kidney
transplant recipients off
anti-rejection drugs ... study that seeks to transplant stem
cells from a kidney
donor's bone marrow into the recipient, with the ... Sharon Flood of Pingree Grove,
Ill. donated her kidney
to her brother Steven Yelk of Gurnee, Ill., ...
Genzyme Corporation Selects Diplomat Specialty Pharmacy for 2008 Renagel Medicare Part D Assistance Program
... dedicated to products
and services focused in kidney
disease, rare inherited disorders,
orthopedics, ... of serum phosphorus in
patients with Chronic kidney
Disease (CKD) on dialysis. The Renagel Part ... and
commitment to patients with Chronic kidney
Disease will help support
Genzyme's premier ...
Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure
... "Compositions and Methods
for Augmenting kidney
Function," under national review in all of ... immense potential to our
company products for kidney
failure applications worldwide."
About Kibow ... Biotics in
slowing the progression of chronic kidney
failure or helping patients feel
better. Kibow is ...
Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH
... with PNH,
hemolysis can cause thromboses, kidney
disease, liver dysfunction,
disabling fatigue, ... and anemia.(1-3)
function is common among patients with PNH, (4-8) ... of death in 8 to 18 percent of PNH patients.
damage in PNH patients is likely due to ...